Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin and Vitamin D3 in LADA
NCT02407899Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in latent autoimmune diabetes in adults (LADA), sponsored by The Second Xiangya Hospital. Started Mar 2015; status: completed.
02
Drugs
saxagliptin
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT02407899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407899.